IMPEDANCE-BASED DETERMINATION OF WHETHER A HYPODERMIC NEEDLE IS INSERTED INTO THE SKIN
Techniques are disclosed for using electrical impedance measurements to help determine whether a hypodermic needle has been inserted into the skin, thereby increasing the accuracy of information provided to the stakeholders and/or enabling other functionality based on the determination. This information can be used and/or combined with other information to help determine whether to administer the drug and/or whether the drug has been administered properly.
1 . A method of administering a drug with a hypodermic needle device, the method comprising:
obtaining, at the hypodermic needle device, an indication of drug administration by the hypodermic needle device;
obtaining, at the hypodermic needle device, one or more impedance measurements during a period of time during which the drug is administered by the hypodermic needle device, wherein:
the one or more impedance measurements are taken by one or more impedance sensors of the hypodermic needle device, and
the one or more impedance measurements are indicative of a location of a needle of the hypodermic needle device, relative to a user's skin, during the period of time; and
determining an effectiveness of drug administration with the hypodermic needle device based, at least in part, on the one or more impedance measurements.
2 . The method of claim 1 , wherein the one or more impedance sensors comprise a strain gauge located around a portion of the needle of the hypodermic needle device.
3 . The method of claim 1 , wherein the one or more impedance sensors comprise a strain gauge located between the needle of the hypodermic needle device and at least a portion of a body of the hypodermic needle device.
4 . The method of claim 1 , wherein the one or more impedance sensors measures impedance between an electrode and the needle of the hypodermic needle device.
5 . The method of claim 1 , further comprising sending, to another device, an indication of the determination of the effectiveness of the drug administration with the hypodermic needle device.
6 . The method of claim 5 , wherein:
the indication of the determination of the effectiveness of how the drug was administered comprises an indication that the needle is in tissue, and
the other device comprises a device maintained by a drug adherence or compliance system.
7 . The method of claim 1 , further comprising prohibiting an administration of the drug based on the one or more impedance measurements being outside of an acceptable impedance range.
8 . The method of claim 1 , wherein the obtaining the one or more impedance measurements is in response to receiving a triggering event.
9 . The method of claim 1 , wherein the one or more impedance measurements are indicative of a depth the needle of the hypodermic needle device is inserted into tissue.
10 . A hypodermic needle device, comprising:
one or more impedance sensors configured to take one or more impedance measurements indicative of a location of a needle of the hypodermic needle device, relative to a user's skin, during a period of time in which a drug is administered by the hypodermic needle device; and
a processor communicatively coupled to the one or more impedance sensors and configured to:
obtain an indication of drug administration by the hypodermic needle device;
obtain the one or more impedance measurements; and
responsive to the indication of drug administration, determine an effectiveness of drug administration with the hypodermic needle device based at least in part on the one or more impedance measurements.
11 . The hypodermic needle device of claim 10 , wherein the one or more impedance sensors comprise a strain gauge located around a portion of the needle of the hypodermic needle device.
12 . The hypodermic needle device of claim 10 , wherein the one or more impedance sensors comprise a strain gauge located between the needle of the hypodermic needle device and at least a portion of a body of the hypodermic needle device.
13 . The hypodermic needle device of claim 10 , wherein the one or more impedance sensors are configured to measure impedance between an electrode and the needle of the hypodermic needle device.
14 . The hypodermic needle device of claim 10 , further comprising a communication interface configured to send, to another device, an indication of the determination of the effectiveness of the drug administration with the hypodermic needle device.
15 . The hypodermic needle device of claim 10 , further comprising a dose-dispensing mechanism, wherein the processor is further configured to cause the dose-dispensing mechanism to prohibit further administration of the drug based on the one or more impedance measurements being outside of an acceptable impedance range.
16 . A hypodermic needle device comprising:
means for obtaining, at the hypodermic needle device, an indication of drug administration by the hypodermic needle device;
means for obtaining one or more impedance measurements during a period of time during which a drug is administered by the hypodermic needle device, wherein the one or more impedance measurements are indicative of a location of a needle of the hypodermic needle device, relative to a user's skin, during the period of time; and
means for determining an effectiveness of drug administration with the hypodermic needle device based, at least in part, on the one or more impedance measurements.
17 . The hypodermic needle device of 16 , wherein the means for obtaining one or more impedance measurements comprises a strain gauge located around a portion of the needle of the hypodermic needle device.
18 . The hypodermic needle device of 16 , wherein the means for obtaining one or more impedance measurements comprises a strain gauge located between the needle of the hypodermic needle device and at least a portion of a body of the hypodermic needle device.
19 . The hypodermic needle device of 16 , the means for obtaining one or more impedance measurements measures impedance between an electrode and the needle of the hypodermic needle device.
20 . The hypodermic needle device of 16 , further comprising means for sending, to another device, an indication of the determination of the effectiveness of the drug administration with the hypodermic needle device.
21 . The hypodermic needle device of 20 , further comprising means for generating the indication of the determination of the effectiveness of how the drug was administered such that the indication of the determination of the effectiveness of how the drug was administered comprises an indication that the needle is in tissue.
22 . The hypodermic needle device of 16 , further comprising means for prohibiting further administration of the drug based on the one or more impedance measurements being outside of an acceptable impedance range.
23 . The hypodermic needle device of 16 , wherein the means for obtaining the one or more impedance measurements comprises means for obtaining the one or more impedance measurements responsive to receiving a triggering event.
24 . The hypodermic needle device of 16 , wherein the means for obtaining the one or more impedance measurements comprise means for obtaining the one or more impedance measurements indicative of a depth the needle of the hypodermic needle device is inserted into tissue.
25 . A non-transitory computer-readable medium having instructions embedded thereon for administering a drug with a hypodermic needle device, the instructions comprising computer code for:
obtaining, at the hypodermic needle device, an indication of drug administration by the hypodermic needle device;
obtaining, at the hypodermic needle device, one or more impedance measurements during a period of time during which the drug is administered by the hypodermic needle device, wherein:
the one or more impedance measurements are taken by one or more impedance sensors of the hypodermic needle device, and
the one or more impedance measurements are indicative of a location of a needle of the hypodermic needle device, relative to a user's skin, during the period of time; and
determining an effectiveness of drug administration with the hypodermic needle device based, at least in part, on the one or more impedance measurements.